• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人接种 17DD-YF 初免 1/5 剂次后诱导的中和抗体和细胞介导免疫应答全景图。

Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults.

机构信息

Instituto René Rachou, Fundação Oswaldo Cruz - FIOCRUZ-Minas, Belo Horizonte, MG, Brazil.

Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

出版信息

Sci Rep. 2024 Apr 2;14(1):7709. doi: 10.1038/s41598-024-57645-3.

DOI:10.1038/s41598-024-57645-3
PMID:38565882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10987530/
Abstract

The present study aimed at evaluating the YF-specific neutralizing antibody profile besides a multiparametric analysis of phenotypic/functional features of cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF vaccine, administered as a single subcutaneous injection. The immunological parameters of each volunteer was monitored at two time points, referred as: before (Day 0) [Non-Vaccinated, NV] and after vaccination (Day 30-45) [Primary Vaccinees, PV]. Data demonstrated high levels of neutralizing antibodies for PV leading to a seropositivity rate of 93%. A broad increase of systemic soluble mediators with a mixed profile was also observed for PV, with IFN-γ and TNF-α presenting the highest baseline fold changes. Integrative network mapping of soluble mediators showed increased correlation numbers in PV as compared to NV (532vs398). Moreover, PV exhibited increased levels of Terminal Effector (CD45RACCR7) CD4 and CD8 T-cells and Non-Classical memory B-cells (IgDCD27). Dimensionality reduction of Mass Cytometry data further support these findings. A polyfunctional cytokine profile (TNF-α/IFN-γ/IL-10/IL-17/IL-2) of T and B-cells was observed upon in vitro antigen recall. Mapping and kinetics timeline of soluble mediator signatures for PV further confirmed the polyfunctional profile upon long-term in vitro culture, mediated by increased levels of IFN-γ and TNF-α along with decreased production of IL-10. These findings suggest novel insights of correlates of protection elicited by the 1/5 fractional dose of 17DD-YF vaccine.

摘要

本研究旨在评估 YF 特异性中和抗体谱,以及通过单次皮下注射 17DD-YF 疫苗的 1/5 分数剂量引发的细胞介导反应的表型/功能特征的多参数分析。在两个时间点监测每个志愿者的免疫参数,称为:之前(第 0 天)[未接种,NV]和接种后(第 30-45 天)[初级接种者,PV]。数据表明,PV 的中和抗体水平很高,导致血清阳性率为 93%。还观察到 PV 中系统性可溶性介质的广泛增加,呈混合特征,IFN-γ 和 TNF-α 呈现出最高的基线倍数变化。可溶性介质的综合网络映射显示,与 NV 相比,PV 的相关性数量增加(532 对 398)。此外,与 NV 相比,PV 表现出更高水平的终末效应(CD45RACCR7)CD4 和 CD8 T 细胞和非经典记忆 B 细胞(IgDCD27)。质谱流式细胞术数据的降维进一步支持了这些发现。观察到 T 和 B 细胞的细胞因子谱(TNF-α/IFN-γ/IL-10/IL-17/IL-2)具有多功能性。PV 的可溶性介质特征图谱和动力学时间线进一步证实了长期体外培养中的多功能谱,这是由 IFN-γ 和 TNF-α 水平增加以及 IL-10 产量减少介导的。这些发现为 17DD-YF 疫苗的 1/5 分数剂量引发的保护相关因素提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/0a2971f49b3b/41598_2024_57645_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/5471568c2fc0/41598_2024_57645_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/63cd7a8cf1e3/41598_2024_57645_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/4ba9aa7b62f2/41598_2024_57645_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/8e36f2b2fac2/41598_2024_57645_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/9798aa4dce7f/41598_2024_57645_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/afa0b4b71a24/41598_2024_57645_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/1bb2ca87f4f0/41598_2024_57645_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/8c785fc9c8e9/41598_2024_57645_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/435a3f97a287/41598_2024_57645_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/d9ffe6c00f96/41598_2024_57645_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/0a2971f49b3b/41598_2024_57645_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/5471568c2fc0/41598_2024_57645_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/63cd7a8cf1e3/41598_2024_57645_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/4ba9aa7b62f2/41598_2024_57645_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/8e36f2b2fac2/41598_2024_57645_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/9798aa4dce7f/41598_2024_57645_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/afa0b4b71a24/41598_2024_57645_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/1bb2ca87f4f0/41598_2024_57645_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/8c785fc9c8e9/41598_2024_57645_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/435a3f97a287/41598_2024_57645_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/d9ffe6c00f96/41598_2024_57645_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4869/10987530/0a2971f49b3b/41598_2024_57645_Fig11_HTML.jpg

相似文献

1
Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults.成人接种 17DD-YF 初免 1/5 剂次后诱导的中和抗体和细胞介导免疫应答全景图。
Sci Rep. 2024 Apr 2;14(1):7709. doi: 10.1038/s41598-024-57645-3.
2
Booster dose after 10 years is recommended following 17DD-YF primary vaccination.17DD-YF 初次接种疫苗后,建议 10 年后进行加强剂量接种。
Hum Vaccin Immunother. 2016;12(2):491-502. doi: 10.1080/21645515.2015.1082693.
3
17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children.17DD 和 17D-213/77 黄热病减毒株在初次接种儿童中引发平衡的细胞因子谱。
PLoS One. 2012;7(12):e49828. doi: 10.1371/journal.pone.0049828. Epub 2012 Dec 10.
4
Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination.多参数方法评估 17DD-YF 初免后记忆状态的时机。
PLoS Negl Trop Dis. 2018 Jun 7;12(6):e0006462. doi: 10.1371/journal.pntd.0006462. eCollection 2018 Jun.
5
Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis.先前的生物治疗和 IFN-γ/IL-10 轴的损伤与脊柱关节炎患者对 17DD-YF 疫苗接种的低免疫反应相关。
Vaccine. 2022 Jul 30;40(32):4580-4593. doi: 10.1016/j.vaccine.2022.05.071. Epub 2022 Jun 18.
6
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.17DD 黄热病疫苗接种后儿童和成人的体液和细胞免疫的探索性研究。居住在无黄热病病毒传播地区的人群。
Vaccine. 2022 Jan 31;40(5):798-810. doi: 10.1016/j.vaccine.2021.12.029. Epub 2021 Dec 27.
7
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.单次接种 17DD 黄热病减毒活疫苗后短暂的免疫持久性表明,为保证儿童的保护性免疫,可能需要加强免疫接种。
Front Immunol. 2019 Sep 26;10:2192. doi: 10.3389/fimmu.2019.02192. eCollection 2019.
8
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline.17DD 黄热病疫苗的亚剂量引发等效的病毒学/免疫学动力学时间线。
BMC Infect Dis. 2014 Jul 15;14:391. doi: 10.1186/1471-2334-14-391.
9
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination.计划原发性 17DD 黄热病疫苗接种后,血清生物标志物谱协调自身免疫性疾病患者的血清转化状态。
Sci Rep. 2021 May 17;11(1):10431. doi: 10.1038/s41598-021-89770-8.
10
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.17DD 黄热病加强免疫和长期免疫在巴西疾病流行地区的人群中。
Emerg Infect Dis. 2019 Aug;25(8):1511-1521. doi: 10.3201/eid2508.181432. Epub 2019 Aug 17.

引用本文的文献

1
Challenges in Emerging and Reemerging Arboviral Diseases: The Examples of Oropouche and Yellow Fever.新发和再发虫媒病毒病面临的挑战:奥罗普切病毒病和黄热病实例
Pathogens. 2025 Jun 23;14(7):621. doi: 10.3390/pathogens14070621.
2
Yellow fever outbreaks in South America: Current epidemiology, legacies of the recent past and perspectives for the near future.南美洲的黄热病疫情:当前流行病学、近期遗留问题及近期展望
New Microbes New Infect. 2025 Mar 13;65:101580. doi: 10.1016/j.nmni.2025.101580. eCollection 2025 Jun.
3
B-cell dynamics underlying poor response upon split-inactivated influenza virus vaccination.

本文引用的文献

1
Standardization, validation, and comparative evaluation of a faster and high-performance test for quantification of yellow fever neutralizing antibodies.一种更快、高性能的黄热病中和抗体定量检测方法的标准化、验证和比较评估。
J Immunol Methods. 2023 Nov;522:113568. doi: 10.1016/j.jim.2023.113568. Epub 2023 Sep 23.
2
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.17DD 黄热病疫苗接种后儿童和成人的体液和细胞免疫的探索性研究。居住在无黄热病病毒传播地区的人群。
Vaccine. 2022 Jan 31;40(5):798-810. doi: 10.1016/j.vaccine.2021.12.029. Epub 2021 Dec 27.
3
裂解灭活流感病毒疫苗接种后反应不佳背后的B细胞动力学
Front Immunol. 2024 Nov 20;15:1481910. doi: 10.3389/fimmu.2024.1481910. eCollection 2024.
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.
17DD 黄热病加强免疫和长期免疫在巴西疾病流行地区的人群中。
Emerg Infect Dis. 2019 Aug;25(8):1511-1521. doi: 10.3201/eid2508.181432. Epub 2019 Aug 17.
4
Characterization of Retinopathy Among Patients With Yellow Fever During 2 Outbreaks in Southeastern Brazil.巴西东南部两次黄热病疫情期间患者视网膜病变的特征分析
JAMA Ophthalmol. 2019 Sep 1;137(9):996-1002. doi: 10.1001/jamaophthalmol.2019.1956.
5
Long-Term Protection After Fractional-Dose Yellow Fever Vaccination: Follow-up Study of a Randomized, Controlled, Noninferiority Trial.小剂量黄热病疫苗接种后的长期保护作用:一项随机、对照、非劣效性试验的随访研究。
Ann Intern Med. 2018 Dec 4;169(11):761-765. doi: 10.7326/M18-1529. Epub 2018 Nov 27.
6
Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe.黄热病病毒:阻碍抗击旧敌的知识空白。
Trends Microbiol. 2018 Nov;26(11):913-928. doi: 10.1016/j.tim.2018.05.012. Epub 2018 Jun 19.
7
Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination.多参数方法评估 17DD-YF 初免后记忆状态的时机。
PLoS Negl Trop Dis. 2018 Jun 7;12(6):e0006462. doi: 10.1371/journal.pntd.0006462. eCollection 2018 Jun.
8
Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Final Report.黄热病疫情期间亚单位疫苗的免疫原性 - 最终报告。
N Engl J Med. 2019 Aug 1;381(5):444-454. doi: 10.1056/NEJMoa1710430. Epub 2018 Feb 14.
9
Yellow fever: a major threat to public health.黄热病:对公共卫生的重大威胁。
Lancet. 2018 Feb 3;391(10119):402. doi: 10.1016/S0140-6736(18)30152-1.
10
Intracellular Cytokine Staining on PBMCs Using CyTOF™ Mass Cytometry.使用CyTOF™质谱流式细胞术对外周血单核细胞进行细胞内细胞因子染色。
Bio Protoc. 2015 Jan 5;5(1). doi: 10.21769/BioProtoc.1370.